Carbon Antioxidants to Prevent Diabetic Complications

描述（由申请人提供）：已证明线粒体过度产生超氧化物是各种高血糖损伤途径的共同点。通过补充超氧化物歧化酶使超氧化物产生正常化，消除了晚期糖基化终产物、蛋白激酶C活性、山梨醇浓度和己糖胺途径通量的增加。因此，有人提出，补充抗氧化剂，中断超氧化物的过度生产应具有治疗价值，对广泛的糖尿病并发症，包括肾小球硬化症，多灶性轴突变性，视网膜缺血等。和合成抗氧化剂（依布硒啉、超氧化物歧化酶模拟物等）。虽然已经证明了抗活性氧的能力，但使用补充性天然抗氧化剂的临床研究还远没有得出结论。需要在高血糖条件下对细胞培养物中的抗氧化剂进行额外的测试，并需要新的抗氧化剂分子，其催化去除超氧化物，而不仅仅是每个抗氧化剂分子去除一个超氧化物分子。最近，一类新的合成抗氧化剂已被证明在预防由氧化应激增加引起的其他疾病的小鼠模型中的死亡率方面非常有效。据信，这些新的抗氧化剂的有效性来自于有利的细胞分布和超氧化物的失活的催化机制。该项目将确定这类抗氧化剂的成员是否可以扩展他们以前的成功，在高血糖条件下提供细胞保护，以及赋予他们的好处，延缓由链脲佐菌素诱导的糖尿病大鼠微血管并发症。这项工作的意义在于开发出一种新的有效抗氧化剂，适用于减轻糖尿病相关的衰弱并发症。由于预计到2010年仅在美国糖尿病就将影响超过1700万人，因此预防或大幅减少糖尿病引起的并发症的足够有效的抗氧化剂的影响将对公共健康产生广泛影响。

DESCRIPTION (provided by applicant): Overproduction of superoxide by mitochondria has been demonstrated to be common to various pathways of hypergylcemic damage. Normalizing superoxide production, by supplemental superoxide dismutase e.g., eliminates the increases in advanced glycation end-products, protein kinase C activity, sorbitol concentration, and hexosamine pathway flux. It has therefore been proposed that supplemental antioxidants which interrupt the overproduction of superoxide should have therapeutic value against a wide spectrum of diabetic complications, including glomerulosclerosis, multifocal axonal degeneration, retinal ischemia, etc. While copious in vitro studies on both natural antioxidants (Vitamin E, a-Lipoic Acid, etc.) and synthetic antioxidants (ebselen, supoeroxide dismutatse mimetics, etc.) have demonstrated the ability to scavenge reactive oxygen species, clinical studies using supplemental natural antioxidants are far less conclusive. There are needs for both additional testing of antioxidants in cell cultures under hyperglycemic conditions and new antioxidant molecules that catalytically remove superoxide rather than merely scavenge one superoxide molecule per antioxidant molecule. Recently, a new class of synthetic antioxidants has been shown to be exceedingly effective at preventing mortality in mouse models of other disorders arising from increased oxidative stress. It is believed that the effectiveness of these new antioxidants arises from both a favorable cellular distribution and a catalytic mechanism for the deactivation of superoxide. This project will determine whether members of this class of antioxidants can extend their previous successes to afford protection of cells during hyperglycemic conditions, as well as to confer their benefits for retarding the microvascular complications arising from streptozotocin-induced diabetes in rats. The significance of the proposed work lies in the development of a new class of potent antioxidants suitable for mitigating the debilitating complications associated with diabetes. As diabetes is expected to affect over 17 million people in the USA alone by 2010, the impact of a sufficiently potent antioxidant that prevents or drastically reduces the complications arising from diabetes would have a broad impact on public health.